Aligos Therapeutics, Inc.Aligos Therapeutics, Inc.Aligos Therapeutics, Inc.

Aligos Therapeutics, Inc.

No trades
See on Supercharts

Price target

103.330.000.00%
The 3 analysts offering 1 year price forecasts for ALGS have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to ALGS in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ALGS EPS for the last quarter is −3.07 USD despite the estimation of −2.16 USD. In the next quarter EPS is expected to reach −2.50 USD. Track more of Aligos Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Aligos Therapeutics, Inc. revenue is expected to reach ‪433.33 K‬ USD. Check out Aligos Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, ALGS price target is 103.33 USD with a max estimate of 175.00 USD and a min estimate of 60.00 USD. Check if this forecast comes true in a year, meanwhile watch Aligos Therapeutics, Inc. stock price chart and keep track of the current situation with ALGS news and stock market news.